A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers
Vadakkuppatu Devasenapathi Ramanathan(National Institute of Research in Tuberculosis), Patricia Fast(International AIDS Vaccine Initiative), Burc Barin(Emmes (United States)), Jean‐Louis Excler(International AIDS Vaccine Initiative), Peter Hayes(International AIDS Vaccine Initiative), Makesh Kumar(National Institute of Research in Tuberculosis), Carl Verlinde(International AIDS Vaccine Initiative), Dennis Panicali(Fox Chase Cancer Center), Sonali Kochhar, Dani Vooijs(International AIDS Vaccine Initiative), Paranji Ramaiyengar Narayanan(National Institute of Research in Tuberculosis), Angela Lombardo(International AIDS Vaccine Initiative), Eddy Sayeed(International AIDS Vaccine Initiative), Michelle Seth Smith(Imperial College London), Tony Tarragona-Fiol(Imperial College London), Jill Gilmour(International AIDS Vaccine Initiative), Josephine H. Cox(International AIDS Vaccine Initiative), Jayashri Mahalingam(National Institute of Research in Tuberculosis), Gwynneth Stevens(Development Bank of Southern Africa), James Ackland(International AIDS Vaccine Initiative), Suniti Solomon(YR Gaitonde Centre for AIDS Research and Education), Sekhar Chakrabarty(National Institute of Cholera and Enteric Diseases), Pattabiraman Sathyamoorthy(National Institute of Research in Tuberculosis), Kelley Loughran(Emmes (United States))
Cited by 59
Related Papers
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
|Journal of Virology|1995|513
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
|Proceedings of the National Academy of Sciences|1982|503
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
|The Journal of Immunology|2004|384